TPP1 has been associated with osteoclast degradation of bone [16], localised in the invasive front of tumours [14], positively correlated with breast cancer biomarkers cathepsin G, estrogen and progesterone receptors [17] and increased in other cancers such as thyroid adenocarcinoma and liver cancer [18]. Here, TPP1 is linked to neoplasm.